Protecting the cardiac patient post-MI
Underlying arrhythmia are being missed in a large number of patients with ischaemic heart disease
You will learn:
• To interpret the results from the BIO|GUARD-MI trial of an implantable loop cardiac monitor, which were released at the recent 2022 American College of Cardiology Congress
• To assess the implications of the use of implantable cardiac monitors and their value in reducing the future risk of further cardiac events in post non-ST-elevation myocardial infarction (NSTEMI) patients.